• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4613486)   Today's Articles (0)   Subscriber (49388)
For: Kargbo RB. Tumor-Targeted Bivalent Protein Degradation for Application in Cancer Therapy. ACS Med Chem Lett 2021;12:326-327. [PMID: 33738055 DOI: 10.1021/acsmedchemlett.1c00084] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2021] [Indexed: 12/15/2022]  Open
Number Cited by Other Article(s)
1
Li Z, Ma S, Zhang L, Zhang S, Ma Z, Du L, Li M. Targeted Protein Degradation Induced by HEMTACs Based on HSP90. J Med Chem 2023;66:733-751. [PMID: 36574496 DOI: 10.1021/acs.jmedchem.2c01648] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
2
Shi W, Feng Z, Chi F, Zhou J, Qiu Q, Jiang Y, Chen S, Zhong Y, Jia H, Huang W, Qian H. Structure-based discovery of receptor tyrosine kinase AXL degraders with excellent anti-tumor activity by selectively degrading AXL and inducing methuosis. Eur J Med Chem 2022;234:114253. [DOI: 10.1016/j.ejmech.2022.114253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2021] [Revised: 03/01/2022] [Accepted: 03/02/2022] [Indexed: 11/04/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA